Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

329 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
hATTR Pathology: Nerve Biopsy Results from Italian Referral Centers.
Luigetti M, Romozzi M, Bisogni G, Cardellini D, Cavallaro T, Di Paolantonio A, Fabrizi GM, Fenu S, Gentile L, Grandis M, Marucci G, Massucco S, Mazzeo A, Pareyson D, Romano A, Russo M, Schenone A, Tagliapietra M, Tozza S, Vita G, Sabatelli M. Luigetti M, et al. Among authors: pareyson d. Brain Sci. 2020 Oct 26;10(11):780. doi: 10.3390/brainsci10110780. Brain Sci. 2020. PMID: 33114611 Free PMC article.
Charcot-Marie-Tooth (CMT) 1a duplication at 17p11.2 in Italian families.
Bellone E, Mandich P, Mancardi GL, Schenone A, Uccelli A, Abbruzzese M, Sghirlanzoni A, Pareyson D, Ajmar F. Bellone E, et al. Among authors: pareyson d. J Med Genet. 1992 Jul;29(7):492-3. J Med Genet. 1992. PMID: 1640430 Free PMC article. No abstract available.
The POEMS syndrome: report of six cases.
Pareyson D, Marazzi R, Confalonieri P, Mancardi GL, Schenone A, Sghirlanzoni A. Pareyson D, et al. Ital J Neurol Sci. 1994 Oct;15(7):353-8. doi: 10.1007/BF02339932. Ital J Neurol Sci. 1994. PMID: 7698893
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol [EudraCT no.: 2006-000032-27].
Pareyson D, Schenone A, Fabrizi GM, Santoro L, Padua L, Quattrone A, Vita G, Gemignani F, Visioli F, Solari A; CMT-TRIAAL Group. Pareyson D, et al. Pharmacol Res. 2006 Dec;54(6):436-41. doi: 10.1016/j.phrs.2006.09.001. Epub 2006 Sep 9. Pharmacol Res. 2006. PMID: 17029975 Clinical Trial.
Reliability of clinical outcome measures in Charcot-Marie-Tooth disease.
Solari A, Laurà M, Salsano E, Radice D, Pareyson D; CMT-TRIAAL Study Group. Solari A, et al. Among authors: pareyson d. Neuromuscul Disord. 2008 Jan;18(1):19-26. doi: 10.1016/j.nmd.2007.09.006. Epub 2007 Oct 26. Neuromuscul Disord. 2008. PMID: 17964785 Clinical Trial.
Natural history of CMT1A including QoL: a 2-year prospective study.
Padua L, Pareyson D, Aprile I, Cavallaro T, Quattrone A, Rizzuto N, Vita G, Tonali P, Schenone A. Padua L, et al. Among authors: pareyson d. Neuromuscul Disord. 2008 Mar;18(3):199-203. doi: 10.1016/j.nmd.2007.11.008. Epub 2008 Jan 31. Neuromuscul Disord. 2008. PMID: 18242090
329 results